Advances in Myelofibrosis Treatment and Enhancing Patient Quality of Life : Episode 5

Management of Anemia in Patients With Myelofibrosis

January 31, 2024

By Christine Cooper, RN, BSN
Aaron T. Gerds, MD, MS

Opinion

Video

Christine Cooper, RN, BSN, explains anemia in myelofibrosis is managed by stimulating red blood cell production with medications, transfusions, and newer therapies that may stabilize red cell counts.

EP: 1.Diagnosing Myelofibrosis

EP: 2.Assessing Risk Level of Patients With Myelofibrosis

EP: 3.Educational Resources for Patients Diagnosed With Myelofibrosis

EP: 4.Key Patient Goals for Myelofibrosis Management

Now Viewing

EP: 5.Management of Anemia in Patients With Myelofibrosis

EP: 6.Clinical Data on the Approved JAK Inhibitors for Treatment of Myelofibrosis

EP: 7.Adverse Events Seen With JAK Inhibitors for Myelofibrosis

EP: 8.Assessing Treatment Response in Patients With Myelofibrosis

EP: 9.Best Approaches to Switching Therapies for a Patient With Myelofibrosis

EP: 10.Dosing JAK Inhibitors in Patients With Myelofibrosis

EP: 11.Key Takeaways for Patients With Myelofibrosis

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!

Latest Conference Coverage

Nurses, APPs Key to AE Management as T-Cell Engagers Move Into Solid Tumors

PI3K and AKT Inhibitor Toxicity Advice From a Breast Cancer Expert

Sonrotoclax/Zanubrutinib Generates Durable Response in R/R MCL

Q&A: Nursing Considerations From Immune Cell Effector Therapy Experts

View More Latest Conference Coverage

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777